Modified GRF(1-29) — GHRH analog with four amino acid substitutions for enhanced stability 30 amino acids · No Drug Affinity Complex (DAC) — shorter half-life, pulsatile release profile Research-grade · CAS 863288-34-0 For in vitro GHRH receptor research only
For laboratory research use only. Not for human or veterinary consumption. SKU CND5.
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ |
| Amino Acids | 30 |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.88 g/mol |
| CAS Number | 863288-34-0 |
| Form | Lyophilized powder |
| Quantity | 5mg per vial |
CJC-1295 binds GHRH receptors on pituitary somatotrophs, triggering adenylate cyclase, cAMP accumulation, PKA phosphorylation, and growth hormone vesicle release. The non-DAC form preserves pulsatile GH secretion patterns — closer to what endogenous GHRH produces — while the DAC version creates sustained, multi-day elevation. Published clinical data documents GH increases of 70-107% with IGF-1 elevations around 28% over 16-week observation periods (Khorram et al., JCEM, 1997; PubMed 9141541).
The Drug Affinity Complex is a maleimidopropionic acid derivative that covalently binds serum albumin. With it: half-life jumps to 6-8 days, GH stays elevated constantly. Without it: half-life stays at 30 minutes to 2 hours, GH pulses naturally. Different tools for different research questions. Both available from Heritage Labs USA.
These two target different arms of the GH axis — GHRH receptor vs GHS-R (ghrelin receptor). Preclinical protocols routinely pair them to study dual-pathway somatotroph activation. The CJC-IPA blend combines both in a single vial.
Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.
For laboratory research use only. Not for human or veterinary use.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.